scholarly journals Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma

2021 ◽  
Author(s):  
Kyung‐Nam Koh ◽  
Jung‐Man Namgoong ◽  
Hee Mang Yoon ◽  
Young Ah Cho ◽  
Se Hoon Choi ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Survival Outcomes ◽  
Recent Improvement ◽  
Improvement In Survival

Recent improvement in survival outcomes and reappraisal of prognostic factors in pediatric living donor liver transplantation

2021 ◽  
Author(s):  
Seak Hee Oh ◽  
In Sook Jeong ◽  
Dae Yeon Kim ◽  
Jung‐Man Namgoong ◽  
Won Kyoung Jhang ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Prognostic Factors ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Survival Outcomes ◽  
Donor Liver ◽  
Recent Improvement ◽  
Donor Liver Transplantation ◽  
Improvement In Survival

Nasal and paranasal sinus mucosal melanoma: Long-term survival outcomes and prognostic factors

2021 ◽  
Vol 42 (6) ◽  
pp. 103070
Author(s):  
Nicholas B. Abt ◽  
Lauren E. Miller ◽  
Tara E. Mokhtari ◽  
Derrick T. Lin ◽  
Jeremy D. Richmon ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Paranasal Sinus ◽  
Mucosal Melanoma ◽  
Survival Outcomes ◽  
Term Survival ◽  
Long Term Survival

Prognostic factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish Uterine Sarcoma Group Study-003

2021 ◽  
pp. 100712
Author(s):  
Ali Ayhan ◽  
Kemal Gungorduk ◽  
Ghanim Khatib ◽  
Zeliha Fırat Cüylan ◽  
Nurettin Boran ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Uterine Sarcoma ◽  
Survival Outcomes ◽  
Uterine Leiomyosarcoma

Clinicopathological Prognostic Factors Influencing Survival Outcomes of Vulvar Cancer

2021 ◽  
Author(s):  
Monwanee Muangchang ◽  
Prapaporn Suprasert ◽  
Surapan Khunamornpong
Keyword(s):  
Prognostic Factors ◽  
Progression Free Survival ◽  
Survival Outcomes ◽  
Tumor Diameter ◽  
Large Tumor ◽  
Node Positive ◽  
Kaplan Meier ◽  
Postmenopausal Status ◽  
Vulva Cancer ◽  
Tumor Area

Abstract Backgroud: Squamous cell carcinoma (SCCA) is the most common vulva cancer. This study purpose to evaluate the clinicopathological prognostic factors for survival outcomes of this disease after treated with surgery. Methods: All SCCA vulva cancer patients who underwent surgery between January 2006 and December 2017 were reviewed. The clinicopathological factors were analyzed to identify the prognostic factors for the progression-free survival (PFS) and overall survival (OS) using the Kaplan- Meier method and Cox-Proportional Hazard model.Results: One hundred twenty-five patients were recruited with a median age of 57 years. The recurrence rate was 35.2%. Patients with recurrence revealed a significant poorer five-year OS rate than those who did not recur (23.7% vs. 79.4%, P < 0.001). About 58.1% of palpable groin nodes revealed metastasis. The independent poor prognostic factors for PFS were groin node-positive and a tumor diameter more than 25 mm. whereas postmenopausal status, preoperative tumor area more than 11 cm2, and groin node enlargement were independent poor prognostic factors for OS. Conclusion: Groin node-positive and tumor diameter longer than 25 mm. were independent poor prognostic factors for PFS whereas postmenopausal status, large tumor area than 11 cm2, and enlargement of groin nodes were independent poor prognostic factors for OS. Patients with these factors should be closely followed.

Recent improvement in survival of patients with multiple myeloma: variation by ethnicity

2013 ◽  
Vol 55 (5) ◽  
pp. 1083-1089 ◽  
Author(s):  
Dianne Pulte ◽  
Maria Theresa Redaniel ◽  
Hermann Brenner ◽  
Lina Jansen ◽  
Mona Jeffreys
Keyword(s):  
Multiple Myeloma ◽  
Recent Improvement ◽  
Improvement In Survival

scholarly journals Bioinformatic Analysis: The Role of LINC00634 in Colorectal Carcinoma

2021 ◽  
Author(s):  
Fang Liu ◽  
Fengyihuan Fu ◽  
Yuqiang Nie
Keyword(s):  
Esophageal Cancer ◽  
Regression Analysis ◽  
Prognostic Factors ◽  
Colorectal Carcinoma ◽  
Roc Curve ◽  
Cox Regression ◽  
Survival Outcomes ◽  
Immune Infiltration ◽  
The Relationship

Abstract Background: LINC00634 is highly expressed in esophageal cancer, and its depletion can suppress the viability and induce the apoptosis of esophageal cancer cells. However, there is a lack of studies that examine the relationship between LINC00634 expression and the clinicopathological features, survival outcomes, prognostic factors and tumor immune cell infiltration of colorectal carcinoma (CRC) patients.Objective: We aim at investigating the role of LINC00634 in colorectal carcinoma.Methods: We obtained data from the TCGA (The Cancer Genome Atlas) public database, GTEx (Genotype-Tissue Expression) database and clinical samples. Wilcoxon rank-sum test, Kruskal-Wallis test and logistic regression analysis were employed to assess the relationship between LINC00634 expression and the clinicopathological characteristics of CRC patients. Receiver operating characteristic (ROC) curve was constructed to evaluate the ability of LINC00634 for distinguishing between CRC patients and normal subjects based on the area under the curve (AUC) score. Univariate and multivariate analyses were conducted to evaluate the association between prognostic factors and survival outcomes. Kaplan-Meier curves and Cox regression analysis were employed to determine the contribution of LINC00634 expression to the prognosis of colorectal carcinoma patients. Immune infiltration analysis and Gene Set Enrichment Analysis (GSEA) were conducted to identify the significantly involved functions of LINC00634. Finally, a nomogram was constructed for internal verification based on the Cox regression data.Results: The expression of LINC00634 was upregulated in CRC patients, and markedly associated with N stage, residual tumor, pathological stage, and overall survival (OS) event. ROC curve showed that LINC00634 had strong diagnostic and prognostic abilities (AUC=0.74). The high expression of LINC00634 could predict poor disease specific survival (DSS; P=0.008) and poor overroll survival (OS;P<0.01). The expression of LINC00634 was independently associated with OS in CRC patients (P=0.019). GSEA and immune infiltration analysis demonstrated that LINC00634 expression was involved in gene transcription, epigenetic regulation and the functions of certain types of immune infiltrating cells. The c-index of the nomogram was 0.772 (95％CI: 0.744-0.799).Conclusions: Our study reveals that LINC00634 can serve as a potential prognostic biomarker for CRC patients.

scholarly journals Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection?

Immunotherapy ◽  
2020 ◽  
Author(s):  
Joseph Kattan ◽  
Clarisse Kattan ◽  
Tarek Assi
Keyword(s):  
Cancer Therapy ◽  
Severe Acute Respiratory Syndrome ◽  
Cancer Patients ◽  
Immune Checkpoint Inhibitors ◽  
Checkpoint Inhibitors ◽  
Survival Outcomes ◽  
Toxicity Profile ◽  
Anti Cancer ◽  
Acquired Immunodeficiency ◽  
Improvement In Survival

The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) has been declared a pandemic by the WHO that claimed the lives of thousands of people within a few months. Cancer patients represent a vulnerable population due to the acquired immunodeficiency associated with anti-cancer therapy. Immune checkpoint inhibitors have largely impacted the prognosis of a multitude of malignancies with significant improvement in survival outcomes and a different, tolerable toxicity profile. In this paper, we assess the safety of ICI administration in cancer patients during the coronavirus pandemic in order to guide the usage of these highly efficacious agents.

Sign in / Sign up

Export Citation Format

Share Document